Virpax Pharmaceuticals (VRPX) Competitors $0.40 -0.04 (-9.09%) As of 07/18/2025 12:03 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRPX vs. SHPH, ONCT, TNFA, SLRX, ADXS, BPTH, ATXI, PTEIQ, ASLN, and OGENShould you be buying Virpax Pharmaceuticals stock or one of its competitors? The main competitors of Virpax Pharmaceuticals include Shuttle Pharmaceuticals (SHPH), Oncternal Therapeutics (ONCT), TNF Pharmaceuticals (TNFA), Salarius Pharmaceuticals (SLRX), Ayala Pharmaceuticals (ADXS), Bio-Path (BPTH), Avenue Therapeutics (ATXI), PolarityTE (PTEIQ), ASLAN Pharmaceuticals (ASLN), and Oragenics (OGEN). These companies are all part of the "pharmaceutical products" industry. Virpax Pharmaceuticals vs. Its Competitors Shuttle Pharmaceuticals Oncternal Therapeutics TNF Pharmaceuticals Salarius Pharmaceuticals Ayala Pharmaceuticals Bio-Path Avenue Therapeutics PolarityTE ASLAN Pharmaceuticals Oragenics Shuttle Pharmaceuticals (NASDAQ:SHPH) and Virpax Pharmaceuticals (NASDAQ:VRPX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment. Is SHPH or VRPX more profitable? Shuttle Pharmaceuticals' return on equity of -1,203.10% beat Virpax Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Shuttle PharmaceuticalsN/A -1,203.10% -370.42% Virpax Pharmaceuticals N/A -1,554.34%-338.29% Which has more risk and volatility, SHPH or VRPX? Shuttle Pharmaceuticals has a beta of -1.09, indicating that its share price is 209% less volatile than the S&P 500. Comparatively, Virpax Pharmaceuticals has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Do analysts prefer SHPH or VRPX? Virpax Pharmaceuticals has a consensus price target of $75.00, suggesting a potential upside of 18,650.00%. Given Virpax Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Virpax Pharmaceuticals is more favorable than Shuttle Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Virpax Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals believe in SHPH or VRPX? 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 32.2% of Virpax Pharmaceuticals shares are held by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are held by company insiders. Comparatively, 3.7% of Virpax Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable earnings & valuation, SHPH or VRPX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.92Virpax PharmaceuticalsN/AN/A-$15.19MN/AN/A Does the media prefer SHPH or VRPX? In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than Virpax Pharmaceuticals. MarketBeat recorded 1 mentions for Shuttle Pharmaceuticals and 0 mentions for Virpax Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled Virpax Pharmaceuticals'average media sentiment score. Company Overall Sentiment Shuttle Pharmaceuticals Neutral Virpax Pharmaceuticals Neutral SummaryVirpax Pharmaceuticals beats Shuttle Pharmaceuticals on 5 of the 9 factors compared between the two stocks. Get Virpax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRPX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRPX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRPX vs. The Competition Export to ExcelMetricVirpax PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$497K$817.60M$5.55B$9.40BDividend YieldN/A4.84%3.75%4.03%P/E RatioN/A1.4128.0119.82Price / SalesN/A27.13432.8198.20Price / CashN/A19.5636.1658.27Price / Book0.246.878.125.65Net Income-$15.19M-$4.17M$3.25B$257.91M7 Day Performance13.12%-0.12%1.68%3.38%1 Month Performance43.37%1.85%7.30%11.11%1 Year Performance-99.06%4.45%32.89%18.99% Virpax Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRPXVirpax Pharmaceuticals1.5173 of 5 stars$0.40-9.1%$75.00+18,650.0%-98.8%$497KN/A0.007Gap DownSHPHShuttle Pharmaceuticals0.7637 of 5 stars$3.94-1.0%N/AN/A$1.73MN/A-0.955Positive NewsGap DownONCTOncternal Therapeutics1.5227 of 5 stars$0.53flat$10.00+1,799.0%N/A$1.56M$790K-0.0530TNFATNF PharmaceuticalsN/A$0.10-6.3%N/AN/A$1.45MN/A-0.026Positive NewsGap DownHigh Trading VolumeSLRXSalarius Pharmaceuticals0.2298 of 5 stars$0.68-9.4%N/A-74.8%$1.44MN/A-0.1420Gap DownADXSAyala PharmaceuticalsN/A$0.03-77.4%N/A-77.8%$1.42M$3.24M0.0020Gap DownBPTHBio-Path0.8257 of 5 stars$0.17-1.7%N/A-91.5%$1.37MN/A0.0010Gap DownATXIAvenue Therapeutics2.0627 of 5 stars$0.40+9.6%N/A-87.7%$1.27MN/A0.024Trending NewsGap UpPTEIQPolarityTEN/AN/AN/AN/A$1.24M$810K-0.0560Gap UpASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330OGENOragenics0.0606 of 5 stars$1.41-0.7%N/A-95.6%$1.16MN/A-0.205 Related Companies and Tools Related Companies SHPH Alternatives ONCT Alternatives TNFA Alternatives SLRX Alternatives ADXS Alternatives BPTH Alternatives ATXI Alternatives PTEIQ Alternatives ASLN Alternatives OGEN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRPX) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRPX Stock Alerts